These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29128076)

  • 1. Cost-Effective Flow Cytometry Testing Strategies.
    Leith CP
    Clin Lab Med; 2017 Dec; 37(4):915-929. PubMed ID: 29128076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value-based flow testing of chronic lymphoproliferative disorders: a quality improvement project to develop an algorithm to streamline testing and reduce costs.
    Oberley MJ; Fitzgerald S; Yang DT; Morgan A; Johnson J; Leith C
    Am J Clin Pathol; 2014 Sep; 142(3):411-8. PubMed ID: 25125633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory service.
    Luider J; Cyfra M; Johnson P; Auer I
    Lab Hematol; 2004; 10(2):102-8. PubMed ID: 15224766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve the efficiency of celiac disease diagnosis in the laboratory.
    González DA; de Armas LG; Rodríguez IM; Almeida AA; García MG; Gannar F; de León AC
    J Immunol Methods; 2017 Oct; 449():62-67. PubMed ID: 28733214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of clinical flow cytometry data analysis: recent advances and future challenges.
    Pedreira CE; Costa ES; Lecrevisse Q; van Dongen JJ; Orfao A;
    Trends Biotechnol; 2013 Jul; 31(7):415-25. PubMed ID: 23746659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data.
    Mason EF; Morgan EA; Pinkus GS; Pozdnyakova O
    Int J Lab Hematol; 2017 Apr; 39(2):137-146. PubMed ID: 28133951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited flow cytometry panels on bone marrow specimens reduce costs and predict negative cytogenetics.
    Hoffmann DG; Kim BH
    Am J Clin Pathol; 2014 Jan; 141(1):94-101. PubMed ID: 24343742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing pattern of "smart" flow cytometry (S-FC) to assist the cost-effective diagnosis of HIV, tuberculosis, and leukemias in resource-restricted conditions.
    Janossy G
    Biotechnol J; 2008 Jan; 3(1):32-42. PubMed ID: 18064612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of laboratory testing.
    Hernandez JS
    Arch Pathol Lab Med; 2003 Apr; 127(4):440-5. PubMed ID: 12683871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aligning the flow cytometric evaluation with the diagnostic need: an evidence-based approach.
    Williams-Voorbeijtel D; Sanchez F; Roth CG
    J Clin Pathol; 2017 Sep; 70(9):740-744. PubMed ID: 28183781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilution testing using rapid diagnostic tests in a HIV diagnostic algorithm: a novel alternative for confirmation testing in resource limited settings.
    Shanks L; Siddiqui MR; Abebe A; Piriou E; Pearce N; Ariti C; Masiga J; Muluneh L; Wazome J; Ritmeijer K; Klarkowski D
    Virol J; 2015 May; 12():75. PubMed ID: 25972188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of laboratory in ensuring appropriate test requests.
    Ferraro S; Panteghini M
    Clin Biochem; 2017 Jul; 50(10-11):555-561. PubMed ID: 28284827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference laboratory utilization management.
    Sluss PM
    Clin Chim Acta; 2014 Jan; 427():167-72. PubMed ID: 24140173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of flow cytometry in hematology and immunology.
    McCurley TL; Larson R
    Clin Lab Sci; 1996; 9(6):358-62. PubMed ID: 10165118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data.
    Rajwa B; Wallace PK; Griffiths EA; Dundar M
    IEEE Trans Biomed Eng; 2017 May; 64(5):1089-1098. PubMed ID: 27416585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A limited plasma cell flow cytometry panel with reflex CD138 immunohistochemistry is an optimal workflow process for evaluating plasma cell neoplasms in bone marrow specimens.
    Chen ZW; Perkins SL; Weiss RL; Bahler DW; Hussong JW; Salama ME
    Am J Clin Pathol; 2015 Jan; 143(1):78-83. PubMed ID: 25511145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved laboratory test selection and enhanced perception of test results as tools for cost-effective medicine.
    Mayer M; Wilkinson I; Heikkinen R; Orntoft T; Magid E
    Clin Chem Lab Med; 1998 Sep; 36(9):683-90. PubMed ID: 9804391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for determining costs associated with laboratory error.
    Cavenaugh EL
    Am J Public Health; 1981 Aug; 71(8):831-4. PubMed ID: 6789688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective laboratory testing.
    Burke MD
    Postgrad Med; 1981 Feb; 69(2):191-202. PubMed ID: 6779270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues.
    Davis BH; Dasgupta A; Kussick S; Han JY; Estrellado A;
    Cytometry B Clin Cytom; 2013; 84(5):286-90. PubMed ID: 24022851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.